Ten years experience with chronic prostatitis in Africans

East African Medical Journal

Volumn 73, Issue 3, 1996, Pages 176-178

  Magoha, G A O ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; TRIMETHOPRIM;

ADULT; AFRICA; ARTICLE; CHRONIC PROSTATITIS; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; SYMPTOMATOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; HUMANS; KENYA; MALE; MANDELIC ACIDS; MIDDLE AGED; NIGERIA; PARASYMPATHOLYTICS; PROSTATITIS; RECURRENCE; TREATMENT OUTCOME;

EID: 0029931682     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dobble, A. Chronic prostatitis. Brit. J. Urol. 1994; 74:537-541.
2. Drach, G.W., Fair, W.R., Meares, E.M. and Stamey, T.A. Classification of benign diseases associated with prostatic pain: Prostatitis or prostalodynia? J. Urol. 1978; 120:266.
3. Meares, G.M. Prostatitis syndromes: New perspectives about old woes. J. Urol. 1980; 123:143-147.
4. Meares, E.M. and Stamey, T.A. Bacteriologic localisation patterns in bacterial prostatitis and urethritis. Invest. Urol. 1968; 5:492-518.
5. Schaeffer, A.J., Wendel, E.F., Dunn, J.K. and Graynack, J.T. Prevalence and significance of prostatic inflammation. J. Urol. 1981; 125:215.
6. Brunner, H., Weidner, W. and Schieffer, H.G. Studies of the role of ureplasma urealyticum and mycoplasma hominis in prostatitis. J. infect. Dis. 1983; 147:807.
7. Shortlife, L.M.F., Elliot, K.M. and Sellers, R.G. et al. Measurement of chlamydial and ureaplasmal antibodies in serum and prostatic fluid in men with non bacterial prostatitis (abstr.) J. Urol. 1985; 133:276A.
8. Polleti, F., Medicin, M.C. and Alinovi, A. et al. Isolation of cnlamydia trachomatis from prostatic cells in patients affected by non acute bacterial prostatitis. J. Urol. 1985; 126:625.
9. Bruse, A.W., Willet, W.S. and Chadwick, P. et al. The role of chlamydia in genituurinary disease. J. Urol. 1981; 126:625.
10. Dobble, A., Thomas, B.J. and Walker, M.M. et al. Tke role of chlamydia tracnomatis in chronic Abacterial prostatitis. A study using ultrasound guided biopsy. J. Urol. 1989; 141:332.
11. Berger, R.E., Krieger, J.N., and Kessler, D. Case control study of men with suspected chronic idiopathic prostatitis. J. Urol. 1989; 141:328.
12. Meares, E.M. jr. Prostatodynia: Clinical findings and rationale for treatment. In: Weidner, W., Brunner, H., Krausse, W. and Ruthange, C.F. (Eds): Therapy of prostatitis. Munich W. Zuckswerdt Vercag 1986:207-212.
13. Schaeffer, A.J. Diagnosis and treatment of prostatic infections. Urol. Supp. Vol. XXXVI. 1990:13-17.
14. Jimnez-Cruz, J.F., Tormo, F.B. and Gomez, J.G. Treatment of chronic prostatitis: Intraprostatic antibiotic injections under Echography control. J. Urol. 1988; 139:967-970.
15. Schilds, S.J. Treatment of chronic bacterial prostatitis with ciprofloxacin. Infect. Surg. 1987; 6:649.
16. Meares, E.M. jr. Acute and chronic prostatitis: Diagnosis and treatment. Dis. Clin. N. Amer. 1987; 1:855.
17. Meares, E.M. jr. Prostatitis: Review of pharmacokinetics and therapy. Rev. Infect. Dis. 1982; 4:475.
18. Eykyn, S., Bultitude, M.I. and Mayo, M.E. et al. Prostatic calculi as a source of recurrent bacteriuria in the male. Brit. J. Urol. 1974; 46:527.
19. Schaeffer, A.J. and Darras, F.S. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimetboprim sulphomethoxazole and carbenicillin. J. Urol. 1990; 144:90-693.
20. Bergeron, M.g. et al. Norfloxacin penetration into human renal and prostatic tissues. Antimicrob. agenis Chemother. 1985; 28:349-350.
21. Weidner, W., Schaeffer, H.G. and Dalhoff, A. Treatment of chronic bacterial prostatitis with ciprofloxacin, results of one year follow up study. Amer. J. med. (suppl. 4A) 1987; 87:280-283.
22. Waber, K.G. Use of quinolones in Urinary tract infections and prostatitis. Rev. infect. Dis. 1989; II(Suppl. 5):S1321.
23. McNeal, J.E. Regional morphology and pathology of prostrate. Amer. J. clin. Path. 1968; 49:347-357.
24. Blacklock, N.J. Anatomical factors in prostatitis. Brit. J. Urol. 1974; 46:47-54.
25. de la Rosette, J.J.M.C.H., Karthaus, H.F.M., Van Kerrebroeck P.E.V.A., de Boo, T. and Debruyne, F.M.J. Research in prostatitis syndromes; the use of alfusozin in patients mainly presenting with micturition complaints of irritative nature and confirmed urodynamic abnormalities. Europ. Urol. 1992; 22:222-227.
26. Rugendorff, B.W., Weidner, W., Ebeling, L. and Buck, A.C. Results of treatment wia pollen extract (Cernilton in chronic prostatitis and prostatodynia. Brit. J. Urol. 1993; 71:433-438.
27. Servadio C. and Leib, Z. Chronic abacterial prostatitis and hyperthermia: Brit. J. Urol. 1991; 67:308-311.